IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CRVO

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents22.467.948.249.448.3210.509.007.7410.016.377.7910.4215.0014.6510.116.595.979.8737.3140.34
Short-term Investments2.484.9812.6317.8625.2124.7429.9238.9135.08------0.002.9912.4119.2722.5722.68----
Total Current Assets25.9915.1122.8830.6138.0838.5843.0848.8147.337.979.9611.84--18.4022.6426.3229.1833.5737.8240.72
Property, Plant & Equipment------------------------------------0.000.08
Total Non-current Assets*0.000.000.000.000.000.000.000.075.860.030.010.19----0.000.000.000.000.020.17
Total Assets25.9915.1122.8830.6138.0838.5843.0848.8853.198.009.9712.0415.69--22.6426.3229.1833.5737.8440.88
Accounts Payable0.692.271.451.351.851.861.511.080.730.680.660.530.930.971.130.810.850.810.950.68
Total Current Liabilities----4.66------------------------2.272.522.962.932.75
Total Non-current Liabilities*----0.00------------------------0.000.000.000.000.00
Total Liabilities*3.034.504.664.604.643.943.883.253.212.662.602.461.462.132.422.272.522.962.932.75
Retained Earnings(112.23)(105.66)(97.70)(89.61)(81.88)(75.63)(70.73)(64.03)(59.27)(56.96)(54.44)(52.08)(151.80)(149.69)(145.60)(141.52)(138.72)(134.53)(130.01)(126.53)
Total Stockholder Equity*22.9610.6218.2226.0133.4434.6339.2045.6449.985.347.389.5714.2316.2820.2224.0526.6730.6234.9138.13
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue0.000.000.010.321.761.922.161.943.292.352.491.53----------------
Research & Development4.325.145.836.045.114.847.095.133.772.815.271.790.071.311.900.802.112.431.502.11
Selling, General & Admin2.362.982.512.333.272.382.322.212.512.13(1.07)2.412.222.962.342.122.142.131.931.93
Total Operating Expenses6.688.118.348.378.377.229.407.346.284.944.974.20----------------
Operating Income(6.68)(8.11)(8.33)(8.04)(6.62)(5.30)(7.24)(5.40)(3.00)(2.59)1.42(2.68)(2.29)(4.27)(4.25)(2.92)(4.25)(4.55)(12.83)(12.69)
Pretax Income----------------------------(4.08)(2.80)----(3.47)(12.64)
Tax Provision----------------------------0.000.00----0.00(0.44)
Net Income(6.57)(7.96)(8.09)(7.73)(6.26)(4.89)(6.71)(4.75)(2.32)(2.51)1.882.15(2.11)(4.09)(4.08)(2.80)(4.19)(4.53)(3.47)(12.20)
Basic EPS(0.64)(0.86)(0.88)(0.84)(0.70)(0.56)(0.79)(0.55)(0.27)(0.41)1.520.65(1.04)(1.95)(2.00)(1.37)(2.06)(2.22)(0.03)(0.12)
Diluted EPS--------------(0.55)------(0.70)------------(189,601,394.00)101,903,979.00
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(6.92)(8.02)(6.58)(6.47)(6.51)(3.89)(8.05)(4.85)(2.20)(1.42)(2.54)2.70(2.65)(4.97)(3.47)(2.76)(4.01)(4.73)(3.03)(2.97)
Investing Cash Flow2.537.715.377.58(0.25)5.409.312.60(40.57)------3.009.507.003.380.10(22.72)----
Financing Cash Flow18.910.010.000.004.59--0.00(0.01)46.41--(0.09)11.240.000.000.000.000.000.010.000.00
← Scroll for more columns →